Go Back To Menu
Close
Osteosarcoma
MENU

Osteosarcoma Diagnosis

Osteosarcoma is a highly malignant bone tumor, mainly occurring in adolescents and young adults. Without timely diagnosis and treatment in the early stages, the tumor rapidly erodes bone, causing structural destruction and potentially spreading through the bloodstream to the lungs and other distant organs, posing a severe threat. An accurate diagnostic process is key to osteosarcoma treatment, requiring a combination of clinical manifestations, imaging data, and pathological examinations to ensure timeliness and effectiveness of treatment.

Diagnostic Basis

1. Clinical manifestation assessment
Osteosarcoma patients usually present with persistent bone pain, which in the early stages is often mistaken for sports injuries or inflammation. As the tumor grows, a palpable mass may appear locally, accompanied by limited limb movement. A detailed medical history combined with physical examination allows doctors to preliminarily identify potential osteosarcoma and provide a basis for further examinations.

2. Imaging examinations
X-ray is the preferred method for diagnosing osteosarcoma, showing bone destruction, periosteal reaction, and the typical "sunburst" sign. CT scans help assess the extent of tumor invasion into bone and adjacent soft tissues, providing clearer details of bone structure. MRI clearly shows the tumor’s soft tissue involvement and intramedullary spread, aiding surgical planning and staging evaluation. Bone scans are used to detect systemic bone metastases and determine disease extent.

3. Tissue biopsy
Histopathological diagnosis is the gold standard for confirming osteosarcoma. Tumor tissue is obtained through needle or open biopsy, followed by microscopic analysis of cell morphology and structure to determine tumor type and malignancy grade. Biopsy results directly influence treatment planning, ensuring individualized therapy.

4. Molecular and immunological testing
With medical advances, molecular biology testing is increasingly applied in osteosarcoma diagnosis to identify specific gene mutations and expression characteristics of tumors. Immunohistochemical staining helps determine the origin and features of tumor cells, providing a basis for immune reconstruction cell therapy and enhancing treatment precision.

Conclusion

Early and accurate diagnosis of osteosarcoma is critical to improving treatment success rates and patient survival. Experts at United Life International Medical Center emphasize that combining clinical, imaging, and pathological multidisciplinary diagnostics to develop a scientific and rational treatment plan is essential to effectively control the disease and improve patients’ quality of life.